IDiyas

For the Inventor, By the Inventor

San Diego, CA, United States of America

Sherrol Hoffa McDonough

USPTO Granted Patents = 37

Average Co-Inventor Count = 3.5

ph-index = 14

Forward Citations = 1,270(Granted Patents)


Company Filing History:

goldMedal36 out of 818 
 
Gen-probe, Inc.
 patents
silverMedal1 out of 1 
 
Gen-probe Incorported
 patent

Years Active: 1996-2010

Loading Chart...
37 patents (USPTO):Explore Patents
1. 7723040 - Detection of HIV-1 by nucleic acid amplification (2010-05-25),
2. 7425417 - Detection of HIV-1 by nucleic acid amplification (2008-09-16),
3. 7172863 - [object Object] (2007-02-06),
4. 7138516 - Oligonucleotide probes for the detection and/or quantitation of non-viral organisms (2006-11-21),
5. 7097979 - Detection of HIV-1 by nucleic acid amplification (2006-08-29),
6. 7090972 - Methods for determining the presence of non-viral organisms in a sample (2006-08-15),
7. 7087742 - Oligonucleotide probes for the detection and/or quantitation of non-viral organisms (2006-08-08),
8. 7083922 - Detection of HIV (2006-08-01),
9. 7009041 - [object Object] (2006-03-07),
10. 6649749 - Detection of human immunodeficiency virus type 1 (2003-11-18),
11. 6623920 - Detection of HIV-1 by nucleic acid amplification (2003-09-23),
12. 6589734 - Detection of HIV (2003-07-08),
13. 6541201 - Hybridization assay probes and methods for detecting the presence of neisseria meningitiidis subtypes A, C and L in a sample (2003-04-01),
14. 6512105 - Methods for making oligonucleotide probes for the detection and/or quantitation of non-viral organisms (2003-01-28),
15. 6252059 - Detection of human immunodeficiency virus type 1 (2001-06-26),

Title: The Innovative Inventor: Sherrol Hoffa McDonough

Introduction:

Sherrol Hoffa McDonough, a prolific inventor based in San Diego, CA, has made significant contributions to the field of medical diagnostics with an impressive 37 patents to his name. His groundbreaking work in the detection of HIV-1 has revolutionized the way this deadly virus is identified in biological samples.

Latest Patents:

McDonough's latest patents focus on the detection of HIV-1 through nucleic acid amplification. These patents detail nucleic acid sequences and methods for detecting HIV-1 nucleic acid in biological samples by identifying amplified nucleic acids. Additionally, he has developed kits comprising nucleic acid oligomers to amplify HIV-1 nucleic acid and detect the amplified genetic material in a biological sample.

Career Highlights:

Throughout his career, McDonough has been associated with renowned companies such as Gen-Probe, Inc. and Gen-Probe Incorporated. His expertise and dedication to innovation have led to the successful development and implementation of cutting-edge medical technologies.

Collaborations:

McDonough has worked alongside esteemed coworkers, including James John Hogan and Jo Ann Kop, who have played integral roles in the research and development of his patented inventions. Together, they have formed a dynamic team focused on advancing diagnostic solutions for critical healthcare challenges.

Conclusion:

Sherrol Hoffa McDonough's remarkable contributions to the field of medical diagnostics underscore his unwavering commitment to innovation and excellence. His pioneering work in the detection of HIV-1 serves as a beacon of hope in the ongoing fight against infectious diseases, leaving an indelible mark on the landscape of healthcare technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…